Published in Oncology Business Week, January 29th, 2006
Jackson will continue as chairman of the board of directors and stand for re-election at the company's annual meeting on June 15, 2006. On May 1, Sol J. Barer will assume responsibility as the company's CEO. At the same time, Robert J. Hugin will assume Barer's current role as president and chief operating officer.
Jackson has served as chairman and CEO of Celgene since January 1996. His 10-year tenure has been marked by a dramatic strengthening of the company's financial, commercial and research operations that has transformed Celgene into a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week